NCT01934205 - To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 25, 2013

Primary Completion Date

December 21, 2013

Study Completion Date

December 21, 2013

Conditions

Infections, Bacterial

Interventions

DRUG

GSK2140944 (Single dose)

A lyophilized formulation, pale yellow to grayish yellow cake containing 750 mg of GSK2140944 (as free base) per vial, Administered intravenously as a single dose.

DRUG

GSK2140944 (Multiple dose)

A lyophilized formulation, pale yellow to grayish yellow cake containing 750 mg of GSK2140944 (as free base) per vial, Administered intravenously every 12 hours for 5 doses (3 days).

Trial Locations (1)

21225

GSK Investigational Site, Baltimore